Why Did Gavin Newsom Veto Menopause Bill? A Closer Look

California Governor Gavin Newsom vetoed the menopause bill, Senate Bill 1404, on September 28, 2024. He rejected the legislation because of its projected costs and concerns about the state’s financial situation. The bill would have required many large employers to provide menopause-related benefits and training for their workers.

What Did the Menopause Bill Actually Require?

Senate Bill 1404 aimed to expand workplace support for employees going through menopause. The bill targeted private companies with 100 or more employees.

Under the proposed law, employers would have needed to provide reasonable accommodations. These could include things like temperature control adjustments, access to private spaces, and modified uniforms or schedules.

The bill also called for mandatory training for managers and human resources staff. This training would have covered how to recognize menopause symptoms and how to handle accommodation requests fairly.

What Was Newsom’s Official Reason for the Veto?

Governor Newsom stated that the bill’s costs were the main problem. He pointed to the state’s budget deficit, which was estimated at tens of billions of dollars when he issued the veto.

In his veto message, Newsom explained that any new mandate on employers would need to go through the state’s normal budget process. He argued that bypassing that process would create an unpredictable financial burden on businesses.

His message did not question the importance of menopause support in the workplace. Instead, he framed the veto as a fiscal decision rather than a policy disagreement.

Why Did This Bill Matter for Women’s Health?

Menopause is a natural biological stage that typically occurs between ages 45 and 55. It marks the end of menstrual cycles and comes with a drop in estrogen production.

Symptoms vary widely among women. Some experience hot flashes, night sweats, sleep problems, and brain fog. Others have mood changes or joint pain. For many women, these symptoms are mild. For others, they interfere significantly with daily functioning.

A large portion of the workforce falls into this age range. Many women manage menopause symptoms while working full-time jobs, often without any formal workplace support.

Research consistently shows that menopause symptoms can affect work performance and attendance. Some studies suggest that a significant number of women consider reducing their hours or leaving jobs because of unmanaged symptoms.

Did the Bill Have Support from Medical Experts?

Several medical organizations supported the bill. The American College of Obstetricians and Gynecologists has long recognized that menopause can create workplace challenges for women.

Medical support for the bill centered on the idea that workplace accommodations are reasonable. Providing a fan, allowing breaks, or offering flexible schedules are low-cost changes that can help women stay employed and productive.

However, no clinical guidelines currently exist that specifically dictate what workplace accommodations employers must provide for menopause. The bill was creating a new employment standard, not implementing a medical treatment protocol.

Supporters of the bill argued that these accommodations are similar to those already provided for pregnancy. They pointed out that pregnancy accommodations are legally required in California, and menopause support should follow a similar model.

What Did Opponents Say About the Bill?

Business groups opposed the bill from the start. They raised concerns about the cost of implementing new training programs and tracking accommodation requests.

Some opponents argued that the bill’s language was too vague. They said employers might not know exactly what accommodations they needed to provide or how to evaluate requests fairly.

Others worried about legal exposure. If a company failed to provide an accommodation, it could face lawsuits. Smaller businesses near the 100-employee threshold expressed particular concern about added administrative burdens.

These business concerns were not new. Similar arguments have been made against other workplace mandates, including paid sick leave and family leave requirements.

Could the Bill Be Reintroduced in the Future?

Vetoed bills in California can be reintroduced in the next legislative session. Lawmakers can revise the bill to address the governor’s concerns and try again.

Senator Caroline Menjivar, who authored the bill, has indicated she plans to continue working on this issue. She has suggested that future versions might include cost estimates or a different scope to address the governor’s fiscal objections.

The path forward is uncertain. California’s budget situation will play a major role in whether similar legislation can pass in coming years.

Other states are also watching this issue. Some have introduced their own menopause-related workplace legislation, though none have passed laws as extensive as what California proposed.

What Can Women Do in the Meantime?

Women experiencing menopause symptoms at work do not need to wait for legislation. Several practical steps exist right now.

Talking to a healthcare provider is the first step for anyone whose symptoms affect daily life. Treatment options range from lifestyle changes to prescription hormone therapy. The right approach depends on individual symptoms, health history, and personal preference.

At work, women can request informal accommodations through their managers or human resources departments. Many employers are willing to make small changes even without a legal requirement to do so.

Documenting symptoms and their impact on work can be useful. This information helps when discussing needs with a supervisor or when seeking medical care.

Women should also know their existing legal protections. The federal Americans with Disabilities Act may cover some menopause-related conditions if symptoms qualify as a disability. This is determined on a case-by-case basis.

The evidence on menopause treatments is solid for many options. Hormone therapy is well studied and effective for hot flashes and night sweats. Non-hormonal prescription medications also exist for women who cannot or choose not to use hormones.

What Does This Veto Mean for Menopause Awareness?

The veto does not erase the growing conversation about menopause in the workplace. Public awareness has increased significantly in recent years.

More employers are voluntarily creating menopause policies. Some companies now offer menopause leave, flexible scheduling, and cooling options as standard benefits.

Medical education is also improving. More healthcare providers receive training on menopause management than in past decades. The North American Menopause Society offers certification for clinicians who specialize in this area.

The veto is a setback for those who wanted a legal mandate. But the broader movement toward menopause support continues through education, voluntary employer action, and ongoing policy discussions.

What Should Voters Understand About This Decision?

This veto reflects a specific political and fiscal context. It does not represent a medical judgment about menopause or its impact on workers.

California’s budget deficit was a central factor in the decision. The governor’s office has taken a cautious approach to new employer mandates during this period of financial uncertainty.

Voters who care about menopause policy should watch for future legislative efforts. The issue is not closed. It remains an active topic in state capitols and in workplaces across the country.

Understanding the difference between medical evidence and political decision-making matters here. The medical case for menopause support is well established. Whether and how to mandate that support through law is a separate question that involves budgets, business impact, and competing priorities.